Product Description
| Download Documents | |
| SDS |
USER MANUAL CM11439 (1-3 mg scale) |
| USER MANUAL CM11439.01 (0.1 mg scale) |
|
CellMosaic® has designed this kit to label any antibody or protein (≥20 kDa) with PBD dimer using a dipeptide (Val-Ala) linker. Pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) are sequence-selective DNA minor-groove binding agents that inhibit nucleic acid synthesis. PBD dimers, with two PBD units linked via their C8 positions, are more potent DNA alkylating agents than monomers and have been used by several companies to develop antibody-drug conjugates.
Using the kit components along with a user-supplied protein or antibody, users first convert their protein into a thiol-protein through surface amine labeling. The thiol-protein is then reacted with maleimide-activated PBD dimer to generate antibody- or protein-PBD dimer conjugates. The product is then purified to remove any unreacted drug.
Kit is configured to conjugate 6.67-20 nano-mole (nmol) of one (CM11439x1) or three antibodies or proteins (CM11439x3) with the talirine (SGD-1910) PBD dimer using a valine-alanine linker.
If you have a smaller amount of protein, a protein with a MW below 20KDa, or other customization needs, please select the customization radio button and/or fill out the information above.
Drug Information
- Name: Mc-Val-Ala-PBD Dimer (Talirine, SGD-1910)
- CAS number: 1342820-51-2
- Chemical formula: C60H64N8O12
- MW: 1089.2
- Mechanism of action: Sequence-selective DNA minior-groove binding agents, inhibition of nucleic acid synthesis
- Activities: Antitumor
Requirement for Antibody or Protein
- Preferably >90% pure by gel electrophoresis
- Total amount: 6.67-20 nano-mole (nmol) protein content as measured by UV.
Note: the accuracy of your antibody or protein measurement is the single most important factor in obtaining an optimized DAR or DPR of 2-4.
Key Features of this PerKit™
- Simple and efficient labeling of antibody or protein with PBD dimer, minimizing toxin exposure.
- Features an enzymatic dipeptide (Val-Ala) linker.
- Fast and easy preparation: 6 h preparation and less than 2 hours of hands-on time
- All reagents and supplies included for preparation and purification
- Options to choose tailored services at CellMosaic® after conjugation
After conjugation: you can choose to send your sample to CellMosaic® for HPLC analysis and determination of the DAR.
Conjugation Chemistry
Protocol
Schematic workflow diagram for preparing Antibody- or Protein-PBD dimer conjugates with Val-Ala linker, starting with 20 nmol of antibody or protein (Reagent volume will vary if the amount of antibody or protein is less than 20 nmol).
Related Products
Hydrophobic Interaction Chromatography (HIC) Buffer Set (Product#: CM02025): For ADCs prepared via a reduced thiol of the antibody, HIC HPLC is used to calculate the DAR and the heterogeneity of the ADCs. The conjugates are separated based on hydrophobicity. Antibodies loaded with the same number of drugs (same DAR) will have similar hydrophobicity and be eluted as a single peak. CellMosaic® offers HIC buffer for our customers to use with any HIC column. The CM02025 product sheet contains all of the information and methodology needed to run an HIC HPLC analysis. If you do not have access to an HPLC facility, you can send your sample to CellMosaic® for analysis.
Size Exclusion Chromatography (SEC) HPLC Protein Standards (Product #: CM92004 and CM92005): SEC HPLC separates the conjugates by apparent molecular weight (MW) or size in aqueous solution. The larger the MW of the conjugate, the earlier it elutes. By comparing the SEC profile of unlabeled IgG and the ADC, you can estimate how much aggregation is in the ADC. CellMosaic® offers two SEC standards for our customers to use with any SEC column. The CM92004 product sheet contains all of the information and methodology you need to run an SEC HPLC analysis. If you do not have access to an HPLC facility, you can send your sample to CellMosaic® for analysis.
ADC stabilizing PBS buffer (5x) (Product #: CM02022): CM02022 contains 5x PBS buffer and other stabilizers to prevent the hydrophobic drugs from interacting with each other during storage, which would cause the ADCs to precipitate out. Stabilization buffer also helps preserve the structure of the ADCs during lyophilization. The buffer is biocompatible and can be used directly for any in vitro and in vivo studies.
